Windlas Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	5.35	4.24	52.88	36.86	5.7
Short-Term Investments	99.13	154.81	256.39	217.68	1,106
Trading Asset Securities	2,684	2,234	1,734	1,065	648.24
Cash & Short-Term Investments	2,788	2,393	2,044	1,320	1,760
Cash Growth	16.53%	17.08%	54.86%	-25.03%	224.44%
Accounts Receivable	2,274	1,669	1,363	1,169	1,108
Other Receivables	4.3	38.64	6.66	4.38	22.13
Receivables	2,278	1,707	1,369	1,173	1,130
Inventory	618.24	813.84	621.89	747.38	587.1
Prepaid Expenses	13.94	10.54	9.84	8.71	9.54
Other Current Assets	569.83	329.88	268.08	286.61	329.76
Total Current Assets	6,269	5,254	4,313	3,535	3,817
Property, Plant & Equipment	2,660	2,219	1,803	1,227	983.15
Long-Term Investments	-	0.5	16.38	52.44	25.61
Other Intangible Assets	69.11	67.79	44.68	14.84	8.82
Long-Term Deferred Tax Assets	4.48	2.83	5.72	20.25	20.35
Other Long-Term Assets	71.32	59.84	79.54	439.85	55.67
Total Assets	9,073	7,605	6,262	5,290	4,910
Accounts Payable	2,385	1,778	1,315	877.43	632.32
Accrued Expenses	369.94	284.71	336.36	282.13	228.55
Short-Term Debt	-	-	-	-	53.13
Current Portion of Long-Term Debt	298.75	271.17	1.09	3.35	3.64
Current Portion of Leases	32.19	32.29	15.14	15.32	5.16
Current Income Taxes Payable	22.92	-	-	5.91	-
Other Current Liabilities	100.57	127.87	49.81	28.28	17.06
Total Current Liabilities	3,209	2,494	1,718	1,212	939.86
Long-Term Debt	-	-	-	1.09	4.44
Long-Term Leases	21.48	22.51	20.18	30.17	-
Other Long-Term Liabilities	34.32	29.84	25.01	23.36	18.03
Total Liabilities	3,265	2,547	1,763	1,267	962.33
Common Stock	105.53	104.8	103.99	104.63	108.97
Additional Paid-In Capital	2,029	1,989	1,946	1,986	2,269
Retained Earnings	3,473	2,907	2,396	1,900	1,551
Comprehensive Income & Other	201.14	56.99	53.45	32.19	18.04
Total Common Equity	5,808	5,058	4,499	4,023	3,948
Shareholders' Equity	5,808	5,058	4,499	4,023	3,948
Total Liabilities & Equity	9,073	7,605	6,262	5,290	4,910
Total Debt	352.42	325.97	36.41	49.93	66.37
Net Cash (Debt)	2,436	2,067	2,007	1,270	1,694
Net Cash Growth	17.85%	2.97%	58.08%	-25.04%	673.25%
Net Cash Per Share	114.17	97.82	96.16	58.69	82.64
Filing Date Shares Outstanding	20.64	20.96	20.8	20.95	21.79
Total Common Shares Outstanding	21.11	20.96	20.8	20.95	21.79
Working Capital	3,059	2,760	2,595	2,323	2,877
Book Value Per Share	275.20	241.31	216.33	192.05	181.14
Tangible Book Value	5,739	4,990	4,455	4,008	3,939
Tangible Book Value Per Share	271.92	238.08	214.18	191.34	180.73
Land	313.59	313.59	313.59	313.59	215.71
Buildings	811.97	807.45	637.58	489.59	453.6
Machinery	2,150	1,970	1,639	1,005	890.46
Construction In Progress	561.55	32.01	57.08	138.01	75.81